startup

Tubulis

Reimagining Antibody Drug Conjugates Protein-drug conjugates by combining proprietary novel technologies with disease-specific biology.
  • Life Science & Healthcare
  • Startup Stage
  • Sale of Services
  • B2B
  • 2019
  • 1-10 Employees
  • Found
  • Planegg, DE
  • Login required
  • Tubulis GmbH
  • Bayern

Profile is not claimed et

This profile is created by the Startbase Analyst Team. If you are a team member of this company you can claim the profile in order to make changes to it.

Is this your company? Claim profile
Jonas Helma-Smets Geschäftsführer
Dominik Schumacher Geschäftsführer

News about Tubulis

Latest feature of Tubulis:

German Startup Awards 2025 – Die Finalisten
German Startup Awards 2025 – Die Finalisten
Medizintechnik, KI & Nachhaltigkeit: Diese Gründer, Investoren und Innovatoren gestalten die Zukunft – die Finalisten der German Startup Awards 2025 stehen fest!
Startbase
01.04.2025 »

Recent mentions of Tubulis in podcasts & videos:

Jobs at Tubulis:

Related companies

High-Tech Gründerfonds
Investor 2005 Bonn High-Tech Gründerfonds HTGF is one of the leading and most active early-stage investors in Germany and Europe.
Startup 2016 Karlsruhe Ineratec With the innovative chemical reactor technology from INERATEC, gases can be converted on a decentralized scale into liquid energy carriers or valuable chemical products.
Everphone
Startup 2016 Berlin Everphone Everphone rents out mobile company devices such as smartphones, tablets, laptops and accessories with the user-friendly and sustainable “device as a service” concept.
Startup 2017 Berlin Enpal Platform that digitizes the planning of a solar system and mediates between end customers and craftsmen.
Startup 2014 München Scalable Capital Digital asset advisor that creates and monitors customized and globally diversified ETF portfolios for clients.

Other Startups nearby

Startup 2018 Planegg Incyton Automation and optimization of cell-based assays by combining precise sensor technology for key cellular parameters and tuned actuator technology.
Startup 2022 Planegg OmicsChart (Planegg) Platform for neopeptide identification using sequencing data from individual patients.
Startup 2010 Planegg Lindis Biotech Development of Triomab® antibodies - a new class of T-cell activating bispecific antibodies that enable the immune system to transform malignant cancers into treatable and potentially curable diseases.
Startup 2013 Planegg Bind-X Industrial applications in the field of biotechnology.
Startup 2016 Planegg SciRhom Developing drugs to combat life-threatening diseases.

FYI: English edition available

Hello my friend, have you been stranded on the German edition of Startbase? At least your browser tells us, that you do not speak German - so maybe you would like to switch to the English edition instead?

Go to English edition

FYI: Deutsche Edition verfügbar

Hallo mein Freund, du befindest dich auf der Englischen Edition der Startbase und laut deinem Browser sprichst du eigentlich auch Deutsch. Magst du die Sprache wechseln?

Deutsche Edition öffnen